Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPL
601
DELISTED
Buckeye Partners, L.P.
BPL
| $13.3M | 0.03% |
+189,134
| New | +$12.3M |
|
|
ALTR
602
DELISTED
Altera Corp
ALTR
| $13.2M | 0.03% |
+401,473
| New | +$13.2M |
|
603
Carnival Corporation Ltd
CCL
$37.1B
| $13.2M | 0.03% |
+385,000
| New | +$13M |
|
604
Arthur J. Gallagher & Co
AJG
$65.1B
| $13.2M | 0.03% |
+301,400
| New | +$13M |
|
|
JAH
605
DELISTED
JARDEN CORPORATION
JAH
| $13.1M | 0.03% |
+450,636
| New | +$13.5M |
|
606
Regency Centers
REG
$15.1B
| $13.1M | 0.03% |
+258,200
| New | +$13.8M |
|
|
VVC
607
DELISTED
Vectren Corporation
VVC
| $13.1M | 0.03% |
+386,600
| New | +$13.7M |
|
|
EXK
608
Endeavour Silver
EXK
$2.35B
| $13.1M | 0.03% |
+3,807,399
| New | +$17.3M |
|
609
Public Storage
PSA
$60.5B
| $13M | 0.03% |
+84,600
| New | +$13.3M |
|
|
PARAA
610
DELISTED
Paramount Global Class A
PARAA
| $13M | 0.03% |
+265,600
| New | +$12.7M |
|
611
American Vanguard Corp
AVD
$75.2M
| $12.9M | 0.03% |
+551,166
| New | +$16M |
|
|
MENT
612
DELISTED
Mentor Graphics Corp
MENT
| $12.9M | 0.03% |
+657,398
| New | +$12.1M |
|
|
FST
613
DELISTED
FOREST OIL CORPORATION
FST
| $12.8M | 0.03% |
+3,141,195
| New | +$14.3M |
|
|
PGTI
614
DELISTED
PGT, Inc.
PGTI
| $12.7M | 0.03% |
+1,470,129
| New | +$11.5M |
|
615
Bankunited
BKU
$3.36B
| $12.7M | 0.03% |
+489,900
| New | +$12.4M |
|
|
PTNR
616
DELISTED
Partner Communications
PTNR
| $12.7M | 0.03% |
+2,030,711
| New | +$13.4M |
|
617
General Dynamics
GD
$105B
| $12.7M | 0.03% |
+162,200
| New | +$12.1M |
|
618
National Health Investors
NHI
$3.84B
| $12.7M | 0.03% |
+211,495
| New | +$13.7M |
|
|
SGEN
619
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.6M | 0.03% |
+402,013
| New | +$14M |
|
620
Mercury Insurance
MCY
$6.01B
| $12.6M | 0.03% |
+287,000
| New | +$12.3M |
|
|
ORIT
621
DELISTED
Oritani Financial Corp. New
ORIT
| $12.6M | 0.03% |
+804,105
| New | +$12.3M |
|
622
Fortinet
FTNT
$112B
| $12.6M | 0.03% |
+3,600,000
| New | +$13.4M |
|
623
Unisys
UIS
$245M
| $12.5M | 0.03% |
+568,390
| New | +$11.4M |
|
|
TCP
624
DELISTED
TC Pipelines LP
TCP
| $12.5M | 0.03% |
+258,900
| New | +$11.9M |
|
|
FRX
625
DELISTED
FOREST LABORATORIES INC
FRX
| $12.5M | 0.03% |
+304,700
| New | +$11.8M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.